Trump tweeted that the Drug Industry was running false ads about his new price plan.
On July 24, President Trump signed four executive orders to lower the prices for prescription drugs. He had discussed these orders in previous years but never signed them due to concerns for their practicality and effectiveness. This move set off tensions with the Pharmaceutical Research and Manufacturers of America. They called it a reckless distraction impeding their ability to respond to the pandemic and those that could be faced in the future.
According to Reuters, on the same day, Trump said he would meet with the drug industry to discuss a negotiation for dropping one of the orders aimed at setting prices for medicines in the U.S. The meeting was, however, canceled.